Top Markets
#1 MowCat MowCat +369.14%
#2 龙虾 (Lobster) 龙虾 (Lobster) +66.90%
#3 SODAX SODAX +51.90%
#4 Cortex Cortex +33.34%
#5 DexNet DexNet +23.19%
#6 OpenEden OpenEden +21.97%
#7 BNB Attestation Service BNB Attestation Service +20.72%
#8 Magma Finance Magma Finance +16.49%
#9 wojak wojak +16.15%
#10 Akedo Akedo +16.13%
Coin of the day
MowCat MowCat
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Avalyn Pharma Inc. Common Stock Avalyn Pharma Inc. Common Stock

Avalyn Pharma Inc. Common Stock

AVLN
Clasificación en acciones #7326
Avalyn Pharma Inc. operates as a biopharmaceutical firm currently in its... Avalyn Pharma Inc. operates as a biopharmaceutical firm currently in its clinical development phase. The company's primary focus is on creating inhaled pharmaceutical products to manage rare lung conditions, including pulmonary fibrosis and various other interstitial lung diseases (ILDs). Richard Glenn Vincent, Mark W. Surber, and Michael J. Kamdar co-founded the enterprise on May 27, 2011, and its corporate headquarters are situated in Boston, Massachusetts.
Precio por acción
$36.75
Última sincronización: 2026-08-27
Capitalización bursátil
$1.63B
Cambio (1 día)
-0.78%
Cambio (1 año)
-
País
US
Comercio Avalyn Pharma Inc. Common Stock (AVLN)

Categoría

Healthcare
Historial de rendimiento por dividendo de Avalyn Pharma Inc. Common Stock (AVLN)
Rendimiento por dividendo (TTM) de Avalyn Pharma Inc. Common Stock (símbolo bursátil: AVLN) al 2026: 0
Rendimiento promedio por dividendo de los últimos 5 años: 0.00%
Historial de rendimiento por dividendo de Avalyn Pharma Inc. Common Stock (AVLN) desde 2026 hasta 2026
Rendimiento por dividendo al final de cada año (TTM)
Año Rendimiento por dividendo Cambiar
Not enough data for the provided dates.
Rendimientos por dividendo (TTM) de empresas similares o competidoras
Empresa Rendimiento por dividendo País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.12%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH